389 results on '"Lawson, Jeffrey H."'
Search Results
2. Six-year outcomes of a phase II study of human-tissue engineered blood vessels for peripheral arterial bypass
3. Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access
4. Bioengineered Human Acellular Vessels
5. Establishing patient-specific criteria for selecting the optimal upper extremity vascular access procedure
6. Arterial reconstruction with human bioengineered acellular blood vessels in patients with peripheral arterial disease
7. Treatment of Arm Swelling in Hemodialysis Patients with Ipsilateral Arteriovenous Access and Central Vein Stenosis: Conversion to the Hemodialysis Reliable Outflow Graft versus Stent Deployment
8. Challenges and novel therapies for vascular access in haemodialysis
9. Bioengineered Human Acellular Vessels
10. Hemodialysis Grafts
11. Society of Interventional Radiology Reporting Standards for Thoracic Central Vein Obstruction: Endorsed by the American Society of Diagnostic and Interventional Nephrology (ASDIN), British Society of Interventional Radiology (BSIR), Canadian Interventional Radiology Association (CIRA), Heart Rhythm Society (HRS), Indian Society of Vascular and Interventional Radiology (ISVIR), Vascular Access Society of the Americas (VASA), and Vascular Access Society of Britain and Ireland (VASBI)
12. Clinical implementation of the Humacyte human acellular vessel: implications for military and civilian trauma care
13. Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials
14. Hemodialysis Reliable Outflow (HeRO) graft creation in upper extremities abandoned due to stent obstruction via recanalization and HeRO outflow component insertion across stent interstices.
15. Six-year outcomes of a phase II study of human-tissue engineered blood vessels for peripheral arterial bypass
16. Chapter 68 - Bioengineered Vascular Grafts
17. Abstract P1017: Tissue Engineered Human Acellular Blood Vessels For Coronary Artery Bypass Grafting
18. Interleukin-9 mediates chronic kidney disease-dependent vein graft disease: a role for mast cells
19. Hemodialysis Grafts
20. Percutaneous Interventions on the Hemodialysis Reliable Outflow Vascular Access Device
21. Forearm versus upper arm grafts for vascular access
22. Bioengineered hemodialysis access grafts
23. Operative and perioperative management of infected arteriovenous grafts
24. Early infection risk with primary versus staged Hemodialysis Reliable Outflow (HeRO) graft implantation
25. Tissue-Engineered Vascular Grafts: Autologous Off-the-Shelf Vascular Access?
26. Assessment of Vascular Contrast and Depiction of Stenoses in Abdominopelvic and Lower Extremity Vasculature: Comparison of Dual-energy MDCT with Digital Subtraction Angiography
27. Decellularized tissue-engineered blood vessel as an arterial conduit
28. Use of autologous blood-derived endothelial progenitor cells at point-of-care to protect against implant thrombosis in a large animal model
29. The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti Implants
30. Hemodialysis Reliable Outflow (HeRO) graft creation in upper extremities abandoned due to stent obstruction via recanalization and HeRO outflow component insertion across stent interstices
31. 307.8: Novel Approach in Pancreatic Islet Transplantation: Acellular Vessel
32. Abstract 12382: Evaluation of Tissue Engineered Human Acellular Vessels as a Blalock-Taussig-Thomas Shunt in a Juvenile Primate Model
33. The Preservation and Handling of Vein Grafts in Current Surgical Practice: Findings of a Survey Among Cardiovascular Surgeons of Top-Ranked US Hospitals
34. sj-docx-1-tej-10.1177_20417314211027714 – Supplemental material for Development of a Bioartificial Vascular Pancreas
35. An Early Study on the Mechanisms that Allow Tissue-Engineered Vascular Grafts to Resist Intimal Hyperplasia
36. A Comparison Between the HeRO Graft and Conventional Arteriovenous Grafts in Hemodialysis Patients
37. Acute in-vivo evaluation of bleeding with GelfoamTM plus saline and Gelfoam plus human thrombin using a liver square lesion model in swine
38. Development of a Bioartificial Vascular Pancreas
39. Reduction of Vascular Intimal-Medial Hyperplasia in Polytetrafluoroethylene Arteriovenous Grafts via Expression of an Inhibitor of G Protein Signaling
40. Costs of repair of abdominal aortic aneurysm with different devices in a multicenter randomized trial
41. Bioengineered human blood vessels
42. Contributors
43. A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation
44. Contributors
45. Coagulopathy and Hemorrhage
46. Recent Clinical and Investigational Applications of Fibrin Sealant in Selected Surgical Specialties
47. Stem cell use in a patient with an ischemic foot ulcer: A case study
48. Exposure to Topical Bovine Thrombin During Surgery Elicits a Response Against the Xenogeneic Carbohydrate Galactose α1-3Galactose
49. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling
50. Use of Aspirin Associates with Longer Primary Patency of Hemodialysis Grafts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.